Innova Captab IPO is a book built issue of Rs 570.00 crores. The issue comprises of fresh issue of Rs 320.00 crore and offer for sale of 0.56 crore shares.
Innova Captab IPO opens for subscription on December 21, 2023 and closes on December 26, 2023. The allotment for the Innova Captab IPO is expected to be finalized on Wednesday, December 27, 2023. Innova Captab IPO will list on BSE, NSE with tentative listing date fixed as Friday, December 29, 2023.
Innova Captab IPO price band is set at ₹426 to ₹448 per share. The minimum lot size for an application is 33 Shares. The minimum amount of investment required by retail investors is ₹14,784. The minimum lot size investment for sNII is 14 lots (462 shares), amounting to ₹206,976, and for bNII, it is 68 lots (2,244 shares), amounting to ₹1,005,312.
ICICI Securities Limited and Jm Financial Limited are the book running lead managers of the Innova Captab IPO, while Kfin Technologies Limited is the registrar for the issue.
Refer to Innova Captab IPO RHP for detailed information.
Innova Captab IPO Details
| IPO Date | December 21, 2023 to December 26, 2023 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price Band | ₹426 to ₹448 per share |
| Lot Size | 33 Shares |
| Total Issue Size | [.] shares (aggregating up to ₹570.00 Cr) |
| Fresh Issue | [.] shares (aggregating up to ₹320.00 Cr) |
| Offer for Sale | 5,580,357 shares of ₹10 (aggregating up to ₹250.00 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 50,082,072 |
Innova Captab IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII (HNI) Shares Offered | Not less than 15% of the Net Issue |
Innova Captab IPO Timeline (Tentative Schedule)
Innova Captab IPO opens on December 21, 2023, and closes on December 26, 2023.
| IPO Open Date | Thursday, December 21, 2023 |
| IPO Close Date | Tuesday, December 26, 2023 |
| Basis of Allotment | Wednesday, December 27, 2023 |
| Initiation of Refunds | Thursday, December 28, 2023 |
| Credit of Shares to Demat | Thursday, December 28, 2023 |
| Listing Date | Friday, December 29, 2023 |
| Cut-off time for UPI mandate confirmation | 5 PM on December 26, 2023 |
Innova Captab IPO Lot Size
Investors can bid for a minimum of 33 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 33 | ₹14,784 |
| Retail (Max) | 13 | 429 | ₹192,192 |
| S-HNI (Min) | 14 | 462 | ₹206,976 |
| S-HNI (Max) | 67 | 2,211 | ₹990,528 |
| B-HNI (Min) | 68 | 2,244 | ₹1,005,312 |
| Lot Size Calculator |
Innova Captab IPO Promoter Holding
The Promoters of the company, namely Manoj Kumar Lohariwala and Vinay Kumar Lohariwala
| Share Holding Pre Issue | 66.85% |
| Share Holding Post Issue |
About Innova Captab Limited
Incorporated in January 2005, Innova Captab Limited is a pharmaceutical company operating in three business segments. Firstly, it provides contract development and manufacturing services to Indian pharmaceutical companies. Secondly, the company has a domestic business dealing in branded generics. And thirdly, the company has an international business that deals in branded generics.
The company’s product portfolio includes tablets, capsules, dry syrups, dry powder injections, ointments and liquid medicines.
In the financial year 2023 and the three months ended June 30, 2023, the company produced and sold more than 600 different types of generics. These products were distributed under the company’s own brands in the Indian market through a network of approximately 5,000 distributors and stockists and over 150,000 retail pharmacies. In addition, Innova Capitab exported its branded generic products to 20 and 16 countries in FY2023 and the three months ended June 30, 2023, respectively.
As of October 31, 2023, the company employed a team of 29 scientists and engineers in its research and development laboratory. The company’s manufacturing facility is located in Buddi, Haryana
The company’s customer base includes Cipla Limited, Glenmark Pharmaceuticals Limited, Wockhardt Limited, Corona Remedies Private Limited, Emcure Pharmaceuticals Limited, Lupin Limited, Intas Pharmaceuticals Limited, Leeford Healthcare Limited, Medley Pharmaceuticals Limited, Cachet Pharmaceuticals Limited, Eris Healthcare Private Limited, Indoco Remedies Limited, J. B. Chemicals and Pharmaceuticals Limited, Oaknet Healthcare Private Limited, Zuventus Healthcare Limited, Ajanta Pharma Limited, Mankind Pharma Limited and Smart Laboratories Private Limited.
As of October 31, 2023, the company has 200 active product registrations and 20 registrations pending renewal with international authorities. In addition, 218 new registration applications are being processed with international authorities.
Innova Captab Limited Financial Information (Restated Consolidated)
Innova Captab Limited’s revenue increased by 16.45% and profit after tax (PAT) rose by 6.26% between the financial year ending with March 31, 2023 and March 31, 2022.
| Period Ended | 30 Jun 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
| Assets | 1,086.16 | 704.41 | 575.48 | 369.62 |
| Revenue | 234.37 | 935.58 | 803.41 | 412.03 |
| Profit After Tax | 17.59 | 67.95 | 63.95 | 34.50 |
| Net Worth | 294.27 | 276.46 | 208.56 | 144.78 |
| Reserves and Surplus | 228.51 | 67.90 | 196.61 | 132.82 |
| Total Borrowing | 441.90 | 235.19 | 198.18 | 45.03 |
| Amount in ₹ Crore |
Key Performance Indicator
Innova Captab IPO Market Cap is Rs 2563.7 Cr and P/E (x) is 31.64.
| KPI | Values |
|---|---|
| P/E (x) | 31.64 |
| Market Cap (₹ Cr.) | 2563.7 |
| ROE | 24.58% |
| ROCE | 22.61% |
| Debt/Equity | 0.85 |
| EPS (Rs) | 14.16 |
| RoNW | 24.58% |
Check Innova Captab IPO Peer Comparison here.
Objects of the Issue (Innova Captab IPO Objectives)
The Company proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects:
- Repayment and / or prepayment in part or in full, of certain outstanding loans of the Company;
- Investment in the Subsidiary, UML, for repayment and / or prepayment in part or full of outstanding loans availed by UML;
- Funding the working capital requirements; and
- General corporate purposes
Innova Captab Limited Contact Details
Innova Captab Limited
601, Proxima,
Plot No. 19, Sector
30 A, Vashi, Navi Mumbai, 400 705
Phone: +91 22 2564 2095
Email: investors@innovacaptab.com
Website: https://www.innovacaptab.com/
Innova Captab IPO Registrar
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: innovacaptab.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/